Evidence map›Paper›PMID 28819111›Full record

Observational studyScientific reports2017

Community outbreaks of group A Streptococcus revealed by genome sequencing.

Claire E Turner, Luke Bedford, Nicholas M Brown, Kim Judge, M Estée Török, Julian Parkhill, Sharon J Peacock

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Genomic analysis and clinical characteristics of a seasonal upsurge of Streptococcus pyogenes emm12.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026
    Article
  3. Evaluating the use of whole-genome sequencing and SangerJournal of medical microbiology · 2026
    Article
  4. Article
  5. Emergence of clade 3Microbiology (Reading, England) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Molecular characterization ofMicrobial genomics · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A review of penicillin binding protein and group AFrontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Genomic analysis of group AJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  19. A Review ofPathogens (Basel, Switzerland) · 2021
    Review
  20. Cryptic prophages within aMicrobial genomics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Claire E TurnerDepartment of Medicine, Imperial College London, London, United Kingdom. c.e.turner@sheffield.ac.uk.ORCID 0000-0002-4458-9748
Luke BedfordClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Nicholas M BrownClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Kim JudgeWellcome Trust Sanger Institute, Cambridge, United Kingdom.
M Estée TörökClinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Cambridge, United Kingdom.ORCID 0000-0002-7069-5958
Sharon J PeacockWellcome Trust Sanger Institute, Cambridge, United Kingdom.ORCID 0000-0002-1718-2782
Cambridge University Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBWellcome Sanger Institute · GBImperial College London · GB

Funding

Department of HealthMedical Research Council MR/N029399/1Wellcome Trust
6 · The paper itself

Abstract

The frequent occurrence of disease outbreaks in humans caused by group A Streptococcus (GAS) is an on-going public health threat. Conventional bacterial typing methods lack the discriminatory power to confidently confirm or refute outbreaks in hospital and community settings. Microbial whole genome sequencing (WGS) provides a potential solution to this, but, there has been limited population-based surveillance with accompanying sequence data. We performed retrospective genomic surveillance of 93 clinical GAS isolates from individuals in a defined geographic region. Detailed clinical information was obtained for closely related clusters of isolates. Genomic sequence data was contextualised through comparison with international data. We identified 18 different emm genotypes within our bacterial population, and revealed both highly diverse and closely related isolates. This high level of diversity was maintained even in the context of international sequence data. We also identified two emm1 clusters, and one emm3 cluster, of closely-related isolates that differed only by 1 to 4 single nucleotide polymorphisms. Analysis of clinical information identified no healthcare associated contact between patients, indicating cryptic community transmission. Our findings suggest that genomic surveillance of GAS would increase detection of transmission and highlight opportunities for intervention.

Indexed as

Community-Acquired InfectionsDisease OutbreaksGenome, BacterialGenotypeHost-Pathogen InteractionsHumansMolecular EpidemiologyMolecular TypingPhylogenyPolymorphism, Single NucleotideRetrospective StudiesStreptococcal InfectionsStreptococcus pyogenesUnited KingdomWhole Genome Sequencing

Identifiers

PMID28819111
PMCPMC5561225
OpenAlexW2744286916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.